M — Mechanism / History
Patient
Marcus Webb, 38M, O+, Bristol UK
Background
Type 2 Diabetes (Metformin 500mg BD, withheld 14:40), Hypertension (Amlodipine 5mg OD)
Incident
Laceration right hand — crampon, Day 3. Wound dressed. Progressive deterioration over 12–48h.
Allergies
NKDA — no known drug allergies
I — Injuries / Findings
Primary Diagnosis
Suspected sepsis — infected right hand wound
Wound
Purulent discharge, warmth and swelling. Lymphangitic tracking 4cm proximal — confirms sepsis source
Neurology
ACVPU C — new confusion, disoriented to time and place
S — Signs (Latest: 15:10)
HR 126 bpm ↑ · RR 26/min ↑ · SpO₂ 94% ↓ · Temp 38.9°C
SBP 84 mmHg ↓ (critical) · Cap refill 3–4s · ACVPU: C
Baseline (pre-expedition): HR 68, SBP 118, SpO₂ 98%
T — Treatment Given
14:35
Doxycycline 100mg oral — first dose of 100mg BD course. Co-amoxiclav unavailable (allocated to Patient B)
14:38
Paracetamol 1g oral — fever control and analgesia
14:40
Metformin withheld — acute illness protocol, lactic acidosis risk
14:40–15:10
Oral fluids encouraged — approx 400ml taken
14:31
Helicopter evacuation requested — sepsis confirmed, immediate evacuation criteria met
Receiving Team Notes
Known T2DM — impaired wound healing, atypical sepsis presentation expected. Metformin withheld 14:40 (last dose estimated 07:00 Day 6); do not restart until haemodynamically stable and oral intake established. Antibiotic cover: doxycycline 100mg BD started 14:35 (first dose given orally — absorption uncertain at SBP 84). Escalate to IV co-amoxiclav or piperacillin-tazobactam on arrival per local protocol. Blood cultures not obtained in field — take on arrival before escalating antibiotics. IV access unavailable in field — oral fluids only. Baseline vitals on file for reference.